Adolescent and Young Adults (AYA) vs. Adult Subjects with Advanced Malignancies Involving the CNS Differences in Responses to Anticancer Drugs

Adolescent and Young Adults (AYA) vs. Adult Subjects with Advanced Malignancies Involving the CNS Differences in Responses to Anticancer Drugs Malignancies of the central nervous systems (brain and spinal cord) occur at every age level of human life; no age group is spared the possibility of developing a primary or secondary central nervous system (CNS) malignancy. [...]

Fast Fact Product Reviews

One of our products – isophosphoramide mustard (IPM) – that was licensed to ZIOPHARM Oncology, Inc. – now known as ‘Palifosfamide’ is moving nicely in Phase III trials. DEKK-TEC was awarded a US patent 7,678,778 for drug composition of matter and the concept. A recent presentation, which received a ‘PICASSO’ award, can be viewed by [...]

DEKK-TEC News

Adolescent and Young Adults (AYA) vs. Adult Subjects with Advanced Malignancies Involving the CNS Differences in Responses to Anticancer Drugs

Adolescent and Young Adults (AYA) vs. Adult Subjects with Advanced Malignancies Involving the CNS Differences in Responses to Anticancer Drugs Malignancies of the central nervous systems (brain and spinal cord) occur at every age level of human life; no age group is spared the possibility of developing a primary or secondary central nervous system (CNS) malignancy. [...]

Fast Fact Product Reviews

One of our products – isophosphoramide mustard (IPM) – that was licensed to ZIOPHARM Oncology, Inc. – now known as ‘Palifosfamide’ is moving nicely in Phase III trials. DEKK-TEC was awarded a US patent 7,678,778 for drug composition of matter and the concept. A recent presentation, which received a ‘PICASSO’ award, can be viewed by [...]

read more >>